Another week, another rollercoaster in the fast-moving world of cannabis.
At Cannabis Wealth, we’ve been following all the big industry and policy news in a week which has seen some important developments..
Meanwhile, over at Cannabis Health, our in depth coverage of the ongoing growth of cannabis as a medical and wellness product continues
Been busy and want to get caught up in a hurry?
Here are the six things you need to read to stay in the loop this week.
1. Germany to vote for reform?
Germany’s national election on September 26 could be a landmark moment for Europe’s cannabis industry.
As Chancellor Angela Merkel prepares to leave the stage, the European Union’s most influential country looks destined for a political shakeup.
It could mark a huge moment for the cannabis industry as Germany’s parliament might swing in favour of legislation.
Here’s everything you need to know about it.
2. Adapt or fail
The pro-drug reform lobby must accept it has failed and change to push its agenda ahead, leading experts have warned.
Speaking at a Global Cannabis Intelligence event about the state of advocacy in the UK, three leading policy advocates set out how they think greater access can be achieved.
The discussion comes week after the 50-year anniversary of the passage of the The Misuse of Drugs Act.
Read the full story here.
3. Isle of Man steps up
The Isle of Man government has declared it is open for business to the medical cannabis industry.
In a big to create 250 new jobs and generate £3m a year for the island, policymakers want it to become ‘a world-leading exporter’.
Applications are now open for licences to produce and distribute treatments on the island, as well as to use it as an export base.
Full details here.
4. Products pulled from shelves
Two batches of medical cannabis products have been recalled by regulators as investigations are carried out, following reports they may be contaminated with mould.
Medical cannabis pharmacy, Dispensary Green and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued a ‘precautionary’ product recall since being made aware of ‘defects’ in patient’s medication.
Concerns were initially raised after a number of medical cannabis patients spotted what they believed to be mould spores in their prescriptions.
Full story here.
5. NFL turns to medical cannabis
The National Football League (NFL) in America is providing $1 million in funding for research into pain management and cannabinoids.
The pain management committee of the NFL and the NFL Players Association announced it would stump up the funding on Tuesday 8 June.
According to the organisation’s news platform, the move is the next step in a shifting attitude towards players who use medicinal cannabis to manage pain from injuries.
You can read more here.
6. More medical cannabis evidence
Researchers have found that the cannabinoids CBD and CBG, when used in combination, are beneficial for treating inflammation in the lungs.
Scientists at King’s College London, working in collaboration with Sativa Wellness Group have published the first results from a study into the impact of cannabinoids on respiratory diseases.
It aimed to investigate the anti-inflammatory effects of the two non-psychotropic cannabinoids alone and in combination, in a model of pulmonary inflammation.
Full details here.
[activecampaign form=31]
